INO
Inovio Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.40
+2.94%Leverage
- Debt / equity
- 1.83x
- Net debt / equity
- -5.38x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.36x
Liquidity & coverage
- Current ratio
- 1.00x
- Quick ratio
- 1.00x
- Cash ratio
- 0.92x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$1.8K
Cash & dividend
- FCF / debt
- -10.09x
- Cash flow / debt
- -10.07x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026